MK-0457, a novel kinase inhibitor, is active in patients with chronic myeloid leukemia or acute lymphocytic leukemia with the T315I BCR-ABL mutation (Q80312874)
Jump to navigation
Jump to search
scientific article published on 21 September 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MK-0457, a novel kinase inhibitor, is active in patients with chronic myeloid leukemia or acute lymphocytic leukemia with the T315I BCR-ABL mutation |
scientific article published on 21 September 2006 |
Statements
MK-0457, a novel kinase inhibitor, is active in patients with chronic myeloid leukemia or acute lymphocytic leukemia with the T315I BCR-ABL mutation (English)
Francis J Giles
Jorge Cortes
Dan Jones
Donald Bergstrom
Hagop Kantarjian
Steven J Freedman
21 September 2006